Viewing Study NCT02302833


Ignite Creation Date: 2025-12-25 @ 2:41 AM
Ignite Modification Date: 2026-03-03 @ 10:17 AM
Study NCT ID: NCT02302833
Status: COMPLETED
Last Update Posted: 2025-07-31
First Post: 2014-11-21
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Cabozantinib S-malate in Treating Patients With Metastatic Pheochromocytomas or Paragangliomas That Cannot Be Removed by Surgery
Sponsor: M.D. Anderson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Locally Advanced Paraganglioma View
None Metastatic Adrenal Gland Pheochromocytoma View
None Metastatic Paraganglioma View
None Regional Adrenal Gland Pheochromocytoma View
None Unresectable Adrenal Gland Pheochromocytoma View
None Unresectable Paraganglioma View
Keywords: